Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-06

Clinical Trial Update: Endoscopic Pancreatic Duct Stenting for Relief of Obstructive Pain in Patients With Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating endoscopic pancreatic duct stenting to relieve obstructive pain in pancreatic cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: WITHDRAWN